Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Melanie C. Zhang"'
Autor:
Dena Zeraatkar, Jasmine Mah, Tyler Pitre, Johnny Su, Melanie C. Zhang, Wryan Helmeczi, Jennifer Tran, Muhammad Faran Khalid, Sonya Cui, Renata Husnudinov, Aaron Jones
Background: Patients with idiopathic pulmonary fibrosis have a poor overall prognosis. Only nintedanib and pirfenidone have been shown to reduce mortality. Objective: This systematic review and meta-analysis aims to assess the efficacy of nintedanib,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11609996cf64941d0ecd737e5f09cd1c
https://doi.org/10.21203/rs.3.rs-589439/v1
https://doi.org/10.21203/rs.3.rs-589439/v1
Autor:
Melanie C. Zhang, Johnny Su, Muhammad Faran Khalid, Brent Guy, Renata Husnudinov, Dena Zeraatkar, Aaron Jones, Tyler Pitre, Sonya Cui, Laura Banfield, Ciaran Scallan, Wryan Helmeczi, Jasmine Mah
Background: Patients with idiopathic pulmonary fibrosis have a poor overall prognosis and there are few evidence based drug therapies that reduce mortality. Objective: This systematic review and meta-analysis aims to assess whether sildenafil reduces
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82bf9edb0f7e46ce5f02999cab6232c8
https://doi.org/10.21203/rs.3.rs-570505/v1
https://doi.org/10.21203/rs.3.rs-570505/v1
Autor:
Tyler Pitre, Muhammad Faran Khalid, Sonya Cui, Melanie C. Zhang, Renata Husnudinov, Jasmine Mah, Wryan Helmczi, Johnny Su, Brent Guy, Ciaran Scallan, Aaron Jones, Dena Zeraatkar
Publikováno v:
Pulmonary Pharmacology & Therapeutics. :102128
Patients with idiopathic pulmonary fibrosis have a poor overall prognosis and there are few evidence-based drug therapies that reduce mortality.We aimed to perform a systematic review and meta-analysis to assess whether sildenafil reduces mortality,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf8a8739f0c2acdb127eb6d036c6918e
https://doi.org/10.1016/j.pupt.2022.102128
https://doi.org/10.1016/j.pupt.2022.102128
Autor:
Tyler Pitre, Jasmine Mah, Sonya Cui, Melanie C. Zhang, Renata Husnudinov, Faran Khalid, Wryan Helmeczi, Johnny Su, Laura Banfield, Aaron Jones
Background: Idiopathic pulmonary fibrosis (IPF) is a respiratory disorder of unknown etiology with a poor prognosis. There are novel therapies that have been studied in randomized controlled trials since the last network meta-analysis that may be of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cbfcd6ec79f68122caf56d7a3386e2cd
https://doi.org/10.21203/rs.3.rs-420792/v1
https://doi.org/10.21203/rs.3.rs-420792/v1